Manufacture and Distribution of Therapeutics in Response to the Coronavirus Disease 2019 (COVID-19) Pandemic
Inactive
Contract Opportunity
Notice ID
W911QY-21-D-0012
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEPT OF THE ARMY
Major Command
AMC
Sub Command
ACC
Sub Command 2
ACC-CTRS
Sub Command 3
ACC-APG
Office
W6QK ACC-APG NATICK
Award Details
- Contract Award Date: Feb 10, 2022
- Contract Award Number: W58P05-22-C-0012
- Task/Delivery Order Number:
- Modification Number:
- Contractor Awarded Unique Entity ID:
General Information
- Contract Opportunity Type: Justification (Updated)
- Updated Published Date: Mar 09, 2022 11:18 am EST
- Original Published Date: Mar 09, 2022 10:57 am EST
- Inactive Policy: 30 days after published date
- Updated Inactive Date: Apr 08, 2022
- Original Inactive Date: Apr 08, 2022
- Initiative:
- None
Classification
- Product Service Code: 6505 - DRUGS AND BIOLOGICALS
- NAICS Code:
- 325412 - Pharmaceutical Preparation Manufacturing
- Place of Performance:
Description
The Department of Health and Human Services (DHHS) seeks to purchase 1,600,000 doses of Eli Lilly LYCoV-1404 (bebtelovimab) contingent upon U.S. Food and Drug Administration (FDA) issuance of an emergency use authorization (EUA) (and any associated biologics license application (BLA) subsequently submitted for this product), for delivery on or before June 30, 2022.
Attachments/Links
Contact Information
Contracting Office Address
- W6QK ACC APG COVID RESPONSE 6472 INTEGRITY COURT BLDG 4401
- ABERDEEN PROVING GROU , MD 21005-0000
- USA
Primary Point of Contact
- Justin Nabity
- justin.a.nabity.civ@army.mil
Secondary Point of Contact
History
- Apr 08, 2022 11:56 pm EDTJustification (Updated)
- Mar 09, 2022 10:57 am ESTJustification (Original)